🤖 Can AI actually help with study design, or is it just another buzzword? Join Derk at #DTRA2024 where he'll challenge assumptions alongside Anindita (Annie) Saha from the FDA, AMIR KALALI, MD, @Melissa Ceroulo from Medidata and Craig Serra from Flatiron. 🎯 Nov 15, 9:25 AM 🤝 Book a meeting with Derk at DTRA here: https://lnkd.in/evFtk58q or DM #ClinicalTrials #AI #DecentralizedTrials Decentralized Trials & Research Alliance (DTRA)
Castor’s Post
More Relevant Posts
-
Check out the article on the clinical trials!
🔬 Accelerating Clinical Trials with AI: A Comprehensive Analysis Clinical trials have traditionally been constrained by manual, error-prone, labor-intensive, and costly procedures, consuming a substantial portion of the 10-12 years it takes a drug to move from a lab to the pharmacy shelf. 🌟The adoption of Artificial Intelligence is rapidly transforming the landscape of clinical trials, offering new capabilities to improve efficiency and optimize processes. In this article, Dan Piekarz and Andrey Sorokin unveil the game-changing role of AI applications in transforming clinical trials. 📊 From trial protocol design to patient recruitment, informed consent, data collection and analysis, safety monitoring, and regulatory compliance, AI offers unprecedented capabilities to streamline processes and enhance efficiency. Join us as we explore the transformative impact of AI on each of these stages: https://lnkd.in/dPRMZBqA #AI #ClinicalTrials #HealthcareInnovation #DataArt 🌐
-
What do Switzerland, CluePoints, and AI have in common? 🌍🌐 The ACDM AI Symposium, of course. Join industry leaders in Basel on June 24–25 to discuss real-world scenarios of AI in clinical trials, particularly in clinical data management, and examine their capabilities and limitations. Register now, and don’t be a stranger—message us to say hello! https://bit.ly/458JS5o #ACDM2024 #ClinicalTrials #ClinicalResearch #AIforClinicalTrials ACDM: Association for Clinical Data Management
-
-
Consultant, Scientific Division at Scantec Recruitment. 0151 666 8980 lukem@scantec.co.uk
As the powers of AI only continue to improve; Check out some of the current amazing uses (and limitations) of AI in healthcare and drug discovery in this article 🤩
Researchers wrestle with accuracy of AI technology used to create new drug candidates
-
🔬 Accelerating Clinical Trials with AI: A Comprehensive Analysis Clinical trials have traditionally been constrained by manual, error-prone, labor-intensive, and costly procedures, consuming a substantial portion of the 10-12 years it takes a drug to move from a lab to the pharmacy shelf. 🌟The adoption of Artificial Intelligence is rapidly transforming the landscape of clinical trials, offering new capabilities to improve efficiency and optimize processes. In this article, Dan Piekarz and Andrey Sorokin unveil the game-changing role of AI applications in transforming clinical trials. 📊 From trial protocol design to patient recruitment, informed consent, data collection and analysis, safety monitoring, and regulatory compliance, AI offers unprecedented capabilities to streamline processes and enhance efficiency. Join us as we explore the transformative impact of AI on each of these stages: https://lnkd.in/dPRMZBqA #AI #ClinicalTrials #HealthcareInnovation #DataArt 🌐
Maximizing Returns: The Strategic Value of AI in Clinical Trial Investments
dataart.com
-
With the ongoing integration of artificial intelligence (AI) in healthcare, the question of regulation is, well, an important one. David Blumenthal and Bakul Patel suggest a unique perspective on how to oversee the use of generative AI models in medical decision-making. Rather than Food and Drug Administration (FDA) oversight, they propose a role for an agency familiar with clinician licensing in ensuring AI outputs align with medical standards. As an example, if a special license was granted by a state medical board to an AI model, the agency could intervene when output was determined to be flawed and either remove a license or provide guidance to get the model back on track. Is this too novel a solution? #AIinMedicine
The Regulation of Clinical Artificial Intelligence
ai.nejm.org
-
Another great whitepaper from TCG Digital showing #AI transforming healthcare and lifescience. Download it today https://lnkd.in/exUx2MqQ
WHITE PAPER
tcgdigital.com
-
Addressing AI Bias: Building Trust in Data-Driven Medicine - MedscapeAddressing bias in AI : Learn how crowdsourcing and transparency can help eliminate disparities and improve trust in AI -driven healthcare ...https://lnkd.in/eYFszYhi
Addressing AI Bias: Building Trust in Data-Driven Medicine
medscape.com
-
Board member and strategic advisor on clinical research technology/data to a portfolio of small and mid-size clinical technology, CRO, HEOR and pharma/biotech companies, as well as a select set of investment companies.
Is your role becoming more involved with AI? If so you should be at this session to familiarise yourself with what the EU AI act has to say.
Explore the scope of the EU AI Act at the 3rd Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials....... The ACDM: Association for Clinical Data Management is delighted to announce that Dr. Pascal Hofer of Roche will present the session “EU AI Act - Innovation or Overregulation?” at the AI Symposium. Pascal said “As part of its digital strategy, the EU wants to regulate Artificial Intelligence (AI) to ensure better conditions for the development and use of this innovative technology. AI can create many benefits, such as better healthcare; safer and cleaner transport; more efficient manufacturing; and cheaper and more sustainable energy. In April 2021, the European Commission proposed the first EU regulatory framework for AI. It says that AI systems that can be used in different applications are analysed and classified according to the risk they pose to users. The different risk levels will mean more or less regulation.” This presentation will look at the background for the AI Act and summarise key components in a nutshell. It will also explore the scope and risk categories, as well as share a use case for AI-based software in a clinical trial scenario. The AI Symposium will take place from 24-25 June 2024 in Basel, Switzerland. Find out more and book your place here: https://lnkd.in/ef-cQ9SN Premier Sponsors: Medidata Solutions, eClinical Solutions, CluePoints, Saama ACDM Board: Robert King, Sverre Bengtsson, Jo Marshall, Nina Reyes, Eva Alder, Richard Davies, Nicola Götz, Anita Kratchmarov, Ashley Howard, Amelie Spieser AI Symposium Steering Group: Richard Davies, Ashley Howard, Marcus Schwabedissen, Tim Armitage, Rob Nichols #clinicalresearch #clinicaltrials #clinicaldatamanagement #clinicaloperations #edc #ACDM #AI #artificialintelligence
-
-
How to Regulate Generative AI in Healthcare 👉 Leer artículo completo -->
How to Regulate Generative AI in Healthcare
hbr.org
-
While the full potential of artificial intelligence in the medical field is still on the horizon, the impact of AI on today's healthcare is already evident, steering the industry toward more consumer-driven care and organizational efficiancies. Read all about it in my latest article:
Uses for AI in Healthcare
nutanix.com
